💊 A new international clinical trial found that oral semaglutide ... population prone to heart attacks, strokes, and related complications, showing similar benefits to its injectable counterpart.

Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...

McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball Chair ... support the fact that oral semaglutide will generate the same CV benefits as the rest of the ...

Early heart benefits before major weight changes One of the most intriguing aspects of semaglutide’s cardiovascular impact is the timing of these benefits. Recent analysis of extensive clinical ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide ... benefits they’re looking for. Some patients with a personal or family history of heart ...

The researchers saw a 26% reduction in non-fatal heart attacks with oral semaglutide and a 12% reduction ... “The same cardiovascular benefits can be derived from the tablet that we’ve seen ...

Oral semaglutide reduced major cardiovascular events by 14% in patients with type 2 diabetes over nearly 4 years. The trial involved 9650 patients with type 2 diabetes and cardiovascular or kidney ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

It helps protect the heart too,” they said ... the U.S. and Europe to update the labelling of oral semaglutide to reflect its cardiovascular benefits. A decision is anticipated in 2025.

“Heart attacks and ... SOUL published simultaneously, oral semaglutide reduced risk of MACE independently of baseline use of SGLT2i and suggests similar benefits in participants with and without ...